The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Truls Østbye; Lesley H Curtis; Leah E Masselink; Steve Hutchison; Alan Wright; Peter E Dans; Kevin A Schulman; Ranga R Krishnan (Profiled Author: Peter Dans)
Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27710, USA. firstname.lastname@example.org
Pharmacoepidemiology and drug safety 2005;14(6):407-15.
PURPOSE: Previous research has suggested an association between use of atypical antipsychotics and onset of diabetes mellitus. We sought to compare the incidence of new onset diabetes among patients receiving atypical antipsychotics, traditional antipsychotics or antidepressants. METHODS: Retrospective cohort study of outpatients with claims for atypical antipsychotics (n = 10 265) compared to controls with claims for traditional antipsychotics (n = 4607), antidepressants (n = 60 856) or antibiotics (n = 59 878) in the administrative claims database of a large pharmaceutical benefit manager between June 2000 and May 2002. Main outcome measures were adjusted and unadjusted incidence rates of diabetes (new cases per 1000 per year) in a 12-month period, as measured using new prescriptions for antidiabetic drugs after a 6-month lead-in period. RESULTS: Annual unadjusted incidence rates of diabetes (new cases per 1000 per year) were 7.5 for atypical antipsychotics, 11.3 for traditional antipsychotics, 7.8 for antidepressants and 5.1 for antibiotics. In multivariable analyses, age, male sex and Chronic Disease Score were associated with greater odds of diabetes onset. There were no statistically significant differences in outcome between the atypical antipsychotic, traditional antipsychotic and antidepressant groups. Multivariable comparisons among specific agents showed increased odds of diabetes for clozapine, olanzapine, ziprasidone and thioridazine (relative to risperidone), but these comparisons did not reach statistical significance. CONCLUSIONS: In a large prescription claims database, outpatients taking atypical antipsychotics did not have higher rates of diabetes onset, compared to subjects taking traditional antipsychotics or antidepressants.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Jonathan M Meyer; Vicki G Davis; Joseph P McEvoy; Donald C Goff; Henry A Nasrallah; Sonia M Davis; Gail L Daumit; John Hsiao; Marvin S Swartz; T Scott Stroup; et al.Schizophrenia research 2008;103(1-3):104-9.
Masafumi Yoshimura; Thomas Koenig; Satoshi Irisawa; Toshiaki Isotani; Keizo Yamada; Mitsuru Kikuchi; Gaku Okugawa; Takami Yagyu; Toshihiko Kinoshita; Werner Strik; et al.Psychopharmacology 2007;191(4):995-1004.
David L Sultzer; Sonia M Davis; Pierre N Tariot; Karen S Dagerman; Barry D Lebowitz; Constantine G Lyketsos; Robert A Rosenheck; John K Hsiao; Jeffrey A Lieberman; Lon S Schneider; et al.The American journal of psychiatry 2008;165(7):844-54.
Appears in this Publication
Author of this Publication